1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 15-ketoprostaglandin f2alpha in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (15-ketoprostaglandin f2alpha) | Trials (15-ketoprostaglandin f2alpha) | Recent Studies (post-2010) (15-ketoprostaglandin f2alpha) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 41 | 3 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blank, ML; Feuerstein, G; Kopin, IJ; Krausz, MM; Snyder, F; Zukowska-Grojec, Z | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 15-ketoprostaglandin f2alpha
Article | Year |
---|---|
Cardiovascular and sympathetic effects of l-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious SHR and WKY rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dinoprost; Epinephrine; Heart Rate; Hemodynamics; Male; Norepinephrine; Platelet Activating Factor; Prostaglandins F; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Thromboxane B2 | 1982 |